Related references
Note: Only part of the references are listed.Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome
Hekmat B. Khoukaz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Inhibition of Plasminogen Activator Inhibitor-1 Activation Suppresses High Fat Diet-Induced Weight Gain via Alleviation of Hypothalamic Leptin Resistance
Shinichiro Hosaka et al.
FRONTIERS IN PHARMACOLOGY (2020)
A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced Diabetes
Gina M. Coudriet et al.
AMERICAN JOURNAL OF PATHOLOGY (2019)
DNA methylation GrimAge strongly predicts lifespan and healthspan
Ake T. Lu et al.
AGING-US (2019)
Projected US State-Level Prevalence of Adult Obesity and Severe Obesity
Zachary J. Ward et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
PAI-1 Exacerbates White Adipose Tissue Dysfunction and Metabolic Dysregulation in High Fat Diet-Induced Obesity
Lin Wang et al.
FRONTIERS IN PHARMACOLOGY (2018)
Inhibition of Plasminogen Activator Inhibitor 1 Attenuates Hepatic Steatosis but Does Not Prevent Progressive Nonalcoholic Steatohepatitis in Mice
Anne S. Henkel et al.
HEPATOLOGY COMMUNICATIONS (2018)
The perilipin family of lipid droplet proteins: Gatekeepers of intracellular lipolysis
Carole Sztalryd et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2017)
Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data
Mohammad Nasser Kabbany et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
A novel plasminogen activator inhibitor-1 inhibitor, TM5441, protects against high-fat diet-induced obesity and adipocyte injury in mice
Lingjuan Piao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Prothrombotic Factors in Histologically Proven Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
An Verrijken et al.
HEPATOLOGY (2014)
PAI-1-regulated extracellular proteolysis governs senescence and survival in Klotho mice
Mesut Eren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Plasminogen Activator Inhibitor-1 Antagonist TM5441 Attenuates Nω-Nitro-L-Arginine Methyl Ester-Induced Hypertension and Vascular Senescence
Amanda E. Boe et al.
CIRCULATION (2013)
FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling
Rudolf Zechner et al.
CELL METABOLISM (2012)
Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010
Katherine M. Flegal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
A chronic high-cholesterol diet paradoxically suppresses hepatic CYP7A1 expression in FVB/NJ mice
Anne S. Henkel et al.
JOURNAL OF LIPID RESEARCH (2011)
Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease
Silvia Sookoian et al.
ATHEROSCLEROSIS (2010)
Homocysteine Supplementation Attenuates the Unfolded Protein Response in a Murine Nutritional Model of Steatohepatitis
Anne S. Henkel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake
Sabine Thuy et al.
JOURNAL OF NUTRITION (2008)
NASH predicts plasma inflammatory biomarkers independently of visceral fat in men
Giovanni Targher et al.
OBESITY (2008)
PAI-1 antagonists: Predictable indications and unconventional applications
Douglas E. Vaughan et al.
CURRENT DRUG TARGETS (2007)
PAI-1 and atherothrombosis
DE Vaughan
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease
B De Taeye et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes
KF Petersen et al.
DIABETES (2005)
Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life
IJ Hickman et al.
GUT (2004)
Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1
LJ Ma et al.
DIABETES (2004)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase
R Zimmermann et al.
SCIENCE (2004)
Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference
BA Neuschwander-Tetri et al.
HEPATOLOGY (2003)
Share Paper
